Sustainable chemo-catalytic process for producing bio-based adipic acid from alginate biofilms. Combines controlled biodegradation with a patented rhenium-catalyzed dehydroxylation step, delivering yields exceeding 95% while replacing harmful chemicals used in conventional adipic acid manufacturing.
This solution offers an environmentally responsible route to adipic acid, a key industrial monomer used in nylon-66, polyurethanes, plasticizers, and lubricants. The approach starts from alginate-based biodegradable films, which are broken down into C6 sugar monomers (mannuronic and guluronic acids), oxidized into aldaric acids, and then converted into adipic acid through a patented chemo-catalytic dehydroxylation step using a heterogeneous rhenium catalyst. By replacing the traditional nitric acid oxidation pathway, which generates nitrous oxide as a byproduct, this process eliminates hazardous reagents and reduces the environmental footprint of adipic acid production. The same alginate feedstock simultaneously supports the manufacture of biodegradable packaging, creating a dual-value proposition for partners in polymers, specialty chemicals, and sustainable materials.
Core process steps:
Key advantages:
Individual process stages, including biofilm biodegradation, sugar oxidation to aldaric acids, and the patented rhenium-catalyzed dehydroxylation, have each been developed and validated at laboratory scale. Catalyst screening, solvent and gas-phase optimization, and yield assessments have been completed for the dehydroxylation step. Future work focuses on integrating the three stages into a single workflow, optimizing reaction conditions for the oxidation step, and scaling the three-phase batch reactor process. The technology is currently at laboratory-to-pilot readiness, suitable for collaborative scale-up, joint development, and sponsored research partnerships aimed at commercial deployment.
Slovenia’s National Institute of Chemistry (Kemijski inštitut) is a leading public research institute based in Ljubljana, bringing together multidisciplinary teams, advanced infrastructure, and close ties with universities to address industry‑relevant challenges. Industry partners engage through contract research, analytical services, collaborative projects, and access to shared facilities such as high‑field NMR, mass spectrometry, and advanced microscopy. Its location near established pharmaceutical and specialty‑chemical manufacturers in Slovenia and Central Europe supports agile partnering, talent pipelines, and rapid technology validation. Research is supported by competitive European Commission programs and national research funding. A dedicated technology transfer office manages IP, licensing, and spinout support, offering clear pathways from discovery to deployment.